Get started
Author

Paul Matte

Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind
2023 · Paul Matte, Michel Ducreux · Case Reports in Oncology · 3
Management of cancer treatments in hemodialysis patients
2023 · Paul Matte, Kevin Bihan, et al. · Bulletin du Cancer · 3
Nouvelles AMMs : enfortumab vedotin–carcinome urothélial avancé (après chimiothérapie à base de sels de platine et immunothérapie)
2022 · Paul Matte, Luca Campedel · Bulletin du Cancer · 3
Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025
2026 · Matthieu Delaye, Paul Matte, et al. · BJC Reports · 2
Perspectives of oncology residents on Master's Degree in Science (MSc) programs: a national descriptive study by the French Association of Residents in Oncology (AERIO)
2024 · P. Matte, A. Rousseau, et al. · ESMO Open · 2
PDF
Abstract C068: Factors associated with primary resistance to immune checkpoint blockade in early phase clinical trials
2023 · Stéphane Champiat, Paul Matte, et al. · Molecular Cancer Therapeutics · 2
2354P Perception of the environmental impact of oncology care: A survey of French and Belgian caregivers
2025 · P. Matte, P-F. Petit, et al. · Annals of Oncology · 1
Multifocal FDG-avid pancreatic pseudomasses mimicking metastases during pembrolizumab for axillary recurrence of triple-negative breast cancer: a case report of immune-related pancreatitis
2026 · Paul Matte, Claire Charpignon, et al. · Frontiers in Oncology
PDF
Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit
2026 · Matthieu Roulleaux Dugage, Camille Mazza, et al. · European Journal of Cancer
Perceptions of the environmental impact of oncology care: A cross-sectional survey of French and Belgian healthcare professionals
2026 · Paul Matte, Pierre-Florent Petit, et al. · The Journal of Climate Change and Health
PDF
Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials
2026 · Paul Matte, Nael Alshatti, et al. · European Journal of Cancer
Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study
2026 · Matthieu Delaye, Paul Matte, et al. · European Journal of Cancer
Evaluation of renal exclusion criteria in early phase oncology trials: A call for modernization
2026 · Paul Matte, Matthieu Delaye, et al. · European Journal of Cancer
132P Two decades of early-phase oncology trials: Real-world trajectories and outcomes of 26,000 patients referred for early phase oncology trials at Gustave Roussy (2007-2023)
2026 · C. Mazza, M. Roulleaux Dugage, et al. · ESMO Open
Abstract PS1-01-10: Chronic Immune-Related Adverse Events after neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: A Real-World cohort analysis
2026 · P. Matte, I. Hacini, et al. · Clinical Cancer Research
Chronic immune-related adverse events following pembrolizumab-based chemoimmunotherapy for early-stage triple-negative breast cancer
2026 · Paul Matte, Lianne Atsama, et al. · SSRN Electronic Journal
Hydration practices during cisplatin administration: a national multicenter survey
2025 · Paul Matte, Arnaud Saillant, et al. · Supportive Care in Cancer
2909P Hydration practices during cisplatin administration: A national multicenter survey
2025 · P. Matte, A. Saillant, et al. · Annals of Oncology
89P Evaluation of exclusion criteria based on renal function in early-phase oncology clinical trials: The EXKID study
2025 · P. Matte, M. Delaye, et al. · ESMO Open
86P Acute kidney injury in patients included in early-phase oncology clinical trials: Results of the AKITEP study
2025 · M. Delaye, P. Matte, et al. · ESMO Open
PDF
Vers une oncologie plus « verte » à l’heure du réchauffement climatique ?
2025 · Anthony Turpin, Paul Matte, et al. · Bulletin du Cancer
Inhibiteurs de point de contrôle immunitaire
2024 · Romain Batton, Paul Matte, et al. · médecine/sciences
Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
2024 · Paul Matte, Matthieu Delaye, et al. · General Hospital Psychiatry
Les publications des internes en oncologie mises en avant dans ITO
2024 · Matte, Paul · Cairn.info
Supplementary Material for: Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind
2023 · P., Matte, M., Ducreux · Figshare
Works count: 26
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type